These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7971476)

  • 41. Biocompatible dialysis membranes and oxidative stress in patients wih end-stage renal disease on maintenance haemodialysis.
    Abdel-Naeem NM; Kandell NF; El-Shamaa AA; Harba TM; Abdel-Hady AA
    J Egypt Soc Parasitol; 2005 Dec; 35(3 Suppl):1173-97. PubMed ID: 16363293
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human erythropoietin improves the blood platelet phospholipid composition in chronically hemodialyzed patients.
    Krawczyk W; Dmoszyńska A; Marczewski K; Ledwozyw A
    Exp Nephrol; 1995; 3(4):265-6. PubMed ID: 8590040
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Platelet activation during haemodialysis: comparison of cuprammonium rayon and polysulfone membranes.
    Thijs A; Grooteman MP; Zweegman S; Nubé MJ; Huijgens PC; Stehouwer CD
    Blood Purif; 2007; 25(5-6):389-94. PubMed ID: 17890860
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biocompatibility study on cuprophane and polysulphone dialysers.
    Taraba I; Polner K; Makó J
    Nephrol Dial Transplant; 1991; 6 Suppl 3():22-5. PubMed ID: 1775261
    [No Abstract]   [Full Text] [Related]  

  • 45. Fundamental Characteristics of the Newly Developed ATA™ Membrane Dialyzer.
    Sunohara T; Masuda T
    Contrib Nephrol; 2017; 189():215-221. PubMed ID: 27951571
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The influence of dialyzer geometry on blood coagulation and biocompatibility.
    Lins LE; Boberg U; Jacobson SH; Kjellstrand C; Ljungberg B; Skröder R
    Clin Nephrol; 1993 Nov; 40(5):281-5. PubMed ID: 8281717
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Changes of serum albumin and C-reactive protein are related to changes of interleukin-6 release by peripheral blood mononuclear cells in hemodialysis patients treated with different membranes.
    Memoli B; Minutolo R; Bisesti V; Postiglione L; Conti A; Marzano L; Capuano A; Andreucci M; Balletta MM; Guida B; Tetta C;
    Am J Kidney Dis; 2002 Feb; 39(2):266-73. PubMed ID: 11840366
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Systemic cardiovascular response in hemodialysis without and with ultrafiltration with membranes of high and low biocompatibility.
    Aakhus S; Bjoernstad K; Jørstad S
    Blood Purif; 1995; 13(5):229-40. PubMed ID: 7546525
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Postdialysis fatigue: lack of effect of a biocompatible membrane.
    Sklar AH; Beezhold DH; Newman N; Hendrickson T; Dreisbach AW
    Am J Kidney Dis; 1998 Jun; 31(6):1007-10. PubMed ID: 9631846
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V; Kes P; Zeljko R; Kusec V
    Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biocompatibility and clinical performance of a new modified cellulose membrane.
    Bosch T; Schmidt B; Samtleben W; Gurland HJ
    Clin Nephrol; 1986; 26 Suppl 1():S22-9. PubMed ID: 3829464
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of membrane contact in hemodialysis-induced granulocyte activation.
    Kolb G; Nolting C; Eckle I; Müller T; Lange H; Havemann K
    Nephron; 1991; 57(1):64-8. PubMed ID: 2046816
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Case studies of clinical hemodialysis membranes: influences of membrane morphology and biocompatibility on uremic blood-membrane interactions and inflammatory biomarkers.
    Westphalen H; Saadati S; Eduok U; Abdelrasoul A; Shoker A; Choi P; Doan H; Ein-Mozaffari F
    Sci Rep; 2020 Sep; 10(1):14808. PubMed ID: 32908160
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Influence of cuprophane membrane surface dialyzers on beta2-microglobulin serum concentration in patients during hemodialysis].
    Szepietowski T; el-Hayek A
    Polim Med; 1993; 23(3-4):43-54. PubMed ID: 8029157
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Immediate effect of hemodialysis with cuprophane membrane and acetate containing dialysis fluid on respiratory function in patients with chronic renal failure].
    Wanic-Kossowska M
    Pol Tyg Lek; 1993 Feb 15-22; 48(7-8):175-7. PubMed ID: 8415262
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The past, present and future of the dialyzer.
    Mineshima M
    Contrib Nephrol; 2015; 185():8-14. PubMed ID: 26023010
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of vitamin E-bonded membrane on the 8-hydroxy 2'-deoxyguanosine level in leukocyte DNA of hemodialysis patients.
    Tarng DC; Huang TP; Liu TY; Chen HW; Sung YJ; Wei YH
    Kidney Int; 2000 Aug; 58(2):790-9. PubMed ID: 10916104
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effects of the dialysis membrane on cytokine release.
    Zaoui P; Hakim RM
    J Am Soc Nephrol; 1994 Mar; 4(9):1711-8. PubMed ID: 8011981
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Loss of phospholipid asymmetry in human platelet plasma membrane after 1-12 days of storage. An ESR study.
    Gaffet P; Bassé F; Bienvenüe A
    Eur J Biochem; 1994 Jun; 222(3):1033-40. PubMed ID: 8026481
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cellulose-ester as membrane materials for hemodialysis.
    Diamantoglou M; Lemke HD; Vienken J
    Int J Artif Organs; 1994 Jul; 17(7):385-91. PubMed ID: 7806425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.